FIGURE

Fig 8

ID

ZDB-FIG-211025-78

Publication

Sullivan et al., 2021 - Efficacy of epetraborole against Mycobacterium abscessus is increased with norvaline

Other Figures

All Figure Page

Back to All Figure Page

Fig 8

A Mutant frequency to 10X MIC₉₀ EPT (0.63 ?g/mL) or 10X MIC₉₀ EPT + 10X MIC₉₀ norvaline (590 ?g/mL) in M. abscessus ATCC 19977 and M. tuberculosis H37Rv. Data shown is mean � SD from biological triplicates. Means compared using Poisson distribution. *, p < 0.0001; ns, no statistical significance. B M. abscessus susceptibility to EPT with norvaline as an adjuvant. Data shown is mean � SD from one experiment representative of three. C EPT in vivo activity in SCID mouse model of M. abscessus lung infection with norvaline supplementation. Rifabutin (RFB) acts as positive control. Data shown is mean � SD of three to five mice per treatment group. Means compared using one-way ANOVA with Tukey?s multiple comparisons test. **, p < 0.007; ***, p < 0.0005; ****; p < 0.0001; ns, no statistical significance.

Expression Data

Expression Detail

Antibody Labeling

Phenotype Data

Phenotype Detail

Acknowledgments

This image is the copyrighted work of the attributed author or publisher, and ZFIN has permission only to display this image to its users. Additional permissions should be obtained from the applicable author or publisher of the image. Full text @ PLoS Pathog.